Aug 29, 2023 7:00am EDT Societal CDMO Announces Closing of $8.3 Million Public Offering of Common Stock
Aug 24, 2023 7:30am EDT Societal CDMO Announces Pricing of $8.3 Million Public Offering of Common Stock
Aug 09, 2023 7:00am EDT Societal CDMO Reschedules Second Quarter 2023 Financial Results Reporting to August 14, 2023
Aug 02, 2023 4:05pm EDT Societal CDMO to Report Financial Results for Second Quarter 2023 on August 9, 2023
Jul 26, 2023 7:00am EDT Societal CDMO Announces Expansion of Controlled Substance Manufacturing Capabilities to Address Expanding Psychedelic Drug Development Market
Jul 10, 2023 7:00am EDT Societal CDMO Selected by Spinnaker Biosciences to Provide CDMO Services to Support Clinical Development of Novel Therapeutic Candidate